Your browser doesn't support javascript.
loading
A polymorphism in ABCA2 is associated with neutropenia induced by capecitabine in Japanese patients with colorectal cancer.
Shibata, Yukitaka; Matsumoto, Natsumi; Murase, Remi; Kubota, Yutaro; Ishida, Hiroo; Shimada, Ken; Fujita, Ken-Ichi.
Afiliación
  • Shibata Y; Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
  • Matsumoto N; Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
  • Murase R; Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
  • Kubota Y; Division of Medical Oncology, Department of Medicine, Showa University School of Medicine, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan.
  • Ishida H; Division of Medical Oncology, Showa University Northern Yokohama Hospital, 35-1 Chigasakichuo, Tsuzuki-ku, Yokohama, 224-8503, Japan.
  • Shimada K; Division of Medical Oncology, Showa University Koto Toyosu Hospital, Koto-ku, Tokyo, 135-8577, Japan.
  • Fujita KI; Division of Cancer Genome and Pharmacotherapy, Department of Clinical Pharmacy, Showa University School of Pharmacy, 1-5-8 Hatanodai, Shinagawa-ku, Tokyo, 142-8555, Japan. k.fujita@med.showa-u.ac.jp.
Cancer Chemother Pharmacol ; 92(6): 465-474, 2023 12.
Article en En | MEDLINE | ID: mdl-37653272

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Capecitabina / Neutropenia Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Capecitabina / Neutropenia Tipo de estudio: Risk_factors_studies Límite: Humans Idioma: En Revista: Cancer Chemother Pharmacol Año: 2023 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Alemania